Found: 45
Select item for more details and to access through your institution.
Conceptualizing a Quantitative Measurement Suite to Evaluate Healthcare Teams.
- Published in:
- Simulation & Gaming, 2022, v. 53, n. 1, p. 75, doi. 10.1177/10468781211066348
- By:
- Publication type:
- Article
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.669786
- By:
- Publication type:
- Article
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR -Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.607840
- By:
- Publication type:
- Article
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.564915
- By:
- Publication type:
- Article
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1601, doi. 10.3390/ijms21051601
- By:
- Publication type:
- Article
Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 66, doi. 10.3390/ijms21010066
- By:
- Publication type:
- Article
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1874, doi. 10.3390/ijms20081874
- By:
- Publication type:
- Article
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68229-6
- By:
- Publication type:
- Article
Role of Genotyping in Non-Small Cell Lung Cancer Treatment: Current Status.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04920-6
- By:
- Publication type:
- Article
Interprofessional Teamwork Among Students in Simulated Codes: A Quasi-Experimental Study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Interprofessional Teamwork Among Students in Simulated Codes: A Quasi-Experimental Study.
- Published in:
- Nursing Education Perspectives (National League for Nursing), 2013, v. 34, n. 5, p. 339, doi. 10.5480/1536-5026-34.5.339
- By:
- Publication type:
- Article
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 596, doi. 10.1093/oncolo/oyae043
- By:
- Publication type:
- Article
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e118, doi. 10.1093/oncolo/oyad238
- By:
- Publication type:
- Article
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. e484, doi. 10.1093/oncolo/oyac051
- By:
- Publication type:
- Article
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. e199, doi. 10.1093/oncolo/oyab047
- By:
- Publication type:
- Article
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. 87, doi. 10.1002/onco.13951
- By:
- Publication type:
- Article
Clinical Impact of Plasma and Tissue Next‐Generation Sequencing in Advanced Non‐Small Cell Lung Cancer: A Real‐World Experience.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1996, doi. 10.1634/theoncologist.2020-0148
- By:
- Publication type:
- Article
Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated with Immune‐Checkpoint Inhibitors.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1128, doi. 10.1634/theoncologist.2018-0563
- By:
- Publication type:
- Article
From Diagnostic‐Therapeutic Pathways to Real‐World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR‐Positive Non‐Small Cell Lung Cancer (MOST Study).
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e318, doi. 10.1634/theoncologist.2018-0712
- By:
- Publication type:
- Article
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e637, doi. 10.1016/j.cllc.2020.12.007
- By:
- Publication type:
- Article
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1468, doi. 10.3390/diagnostics11081468
- By:
- Publication type:
- Article
Notch3 signalling promotes tumour growth in colorectal cancer.
- Published in:
- Journal of Pathology, 2011, v. 224, n. 4, p. 448, doi. 10.1002/path.2895
- By:
- Publication type:
- Article
Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.7232
- By:
- Publication type:
- Article
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918763744
- By:
- Publication type:
- Article
Unusual echocardiographic appearance of a cardiac metastasis from lung carcinoma.
- Published in:
- Journal of Clinical Ultrasound, 2016, v. 44, n. 6, p. 392, doi. 10.1002/jcu.22325
- By:
- Publication type:
- Article
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?
- Published in:
- World Journal of Surgery, 2019, v. 43, n. 5, p. 1385, doi. 10.1007/s00268-019-04908-0
- By:
- Publication type:
- Article
Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.909064
- By:
- Publication type:
- Article
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1308109
- By:
- Publication type:
- Article
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1353889
- By:
- Publication type:
- Article
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5700, doi. 10.3390/cancers14225700
- By:
- Publication type:
- Article
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1303, doi. 10.3390/cancers12051303
- By:
- Publication type:
- Article
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 3671, doi. 10.2147/OTT.S98435
- By:
- Publication type:
- Article
Fictions pansantes. Bibliothérapies d’hier, d’aujourd’hui et d’ailleurs.
- Published in:
- 2024
- By:
- Publication type:
- Book Review
Rire et dialogu.
- Published in:
- 2024
- By:
- Publication type:
- Book Review
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1415470
- By:
- Publication type:
- Article
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1363069
- By:
- Publication type:
- Article
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
- Published in:
- 2024
- By:
- Publication type:
- Letter